The regional conference dedicated to the pharmaceutical industry SeePharma was held

The regional conference dedicated to the pharmaceutical industry SeePharma was held on 18 October 2011. at the Hyatt Regency Hotel in Belgrade.

Conference “The Market for Drugs, positive lists and supply of innovative and generic drugs”

The conference, entitled “The Market for Drugs, positive lists and supply of innovative and generic drugs” was held on 5 October at the Hyatt Hotel in Belgrade.

INOVIA TAKES PART IN CAMPAIGN “#USTUPAM PROSTOR“

INOVIA takes part in the new campaign “#ustupamprostor” in a manner that will give their media space for social responsibility campaigns. From now on our website you can see socially responsible advertising.

INTERVIEW BOJAN TRKULJA MD FOR VREME

Obstacles at every step

“When we are talking about health care, unlike for some other industries, here is much more important not to protect the rights of manufacturers, but the rights of the patient. If we are facing a situation that our patients are waiting for certain drugs two, three or four years longer than in neighboring countries, it is certainly not good ”

11 INOVIA MEMBERS PUBLISH SPONSORSHIPS DATA ON THE FUND WEBSITE

Eleven members of the Fund of the Manufacturers of Innovative Drugs – INOVIA, in accordance with the Ordinance on advertising of drugs or medicinal product, will publish information on symposia they sponsor on the official website of the Fund – www.inovia.rs

STIGMA AS A BARRIER IN THE TREATMENT OF MENTAL DISORDERS

39th Educational Symposium of the Department of Psychiatry of the Clinical Center of Serbia “STIGMA AS A BARRIER IN THE PREVENTION AND TREATMENT OF MENTAL DISORDERS” was held in Belgrade and members of the Fund of the manufacturers of innovative drugs – INOVIA took part in it.

Bojan Trkulja, director of the Innovative Drug Manufacturers Fund – Inovia for Ekonomeast

If you’re not on the list, you are not on the market
In Serbia, for the last three and a half years more than 150 proposals for putting new drugs on the positive list were submitted, all fees were paid, and only one drug reached the list. Policy regulating the area, favors companies with production in Serbia, and that, like the fuel

INOVIA advocates for electronic identification of DRUGS

What is electronic identification of drugs?

Electronic identification of drugs is a process during which on every drug packaging a serial number is applied and it allows monitoring the drug from the moment of production, distribution to pharmacies and ultimately to the issuance of drug to the patient.

Initiative Power to patients PATIENT ADVOCACY SEMINARS

Fund of the manufacturers of innovative drugs INOVIA supported Patient Advocacy Seminars, held in 2011 and organized by the Initiative Power to Patients, in six towns in Serbia: Novi Sad, Zajecar, Subotica, Kragujevac, Valjevo and Nis.

Patient Advocacy Seminars are designed to make patients and associations interested in promoting patients’ rights,

INTERVIEW WITH DR BOJAN TRKULJA, DIRECTOR OF THE INOVIA FUND, Farmakon Magazine

Innovative drugs on the restored positive list

After a three-year break, RZZO brings innovative drugs to the new positive list. The move is welcomed by doctors, patients and representatives of the innovative pharmaceutical industry

Text: mr farm. Ana Savija

The problem of introducing innovative drugs on the positive list of the Institute for Health Insurance has been around for three years. So long in fact no newly synthesized drug was included in the list.

INOVIA SIGNED THE PROTOCOL WITH HIF

HIF has signed a protocol with the Fund of the manufacturers of innovative drugs – INOVIA that provides reduced prices of drugs from the list by 10 percent. The agreement provided by Protocol, applies to drugs at Lists A and A1.